Business
Currency:EUR
2023/FY
Stock NameRevenueRatio
Biopharmaceutical and Diagnostic Solutions881.34M81.20%
Engineering372.81M34.35%
Adjustments, eliminations and unallocated items-168.79M-15.55%
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
EMEA634.05M58.42%
North America317.54M29.26%
APAC102.9M9.48%
South America30.87M2.84%
